2020, the year in which SARS-CoV-2 swept across the globe and plunged humanity into a global pandemic, is slowly drawing to a close. COVID-19 cases have started to climb once more in various corners of the world and the pressing question continues to be: When will we have a vaccine? The answer remains somewhat unclear. […]

A third Long Island company has jumped into the global race to produce COVID-19 vaccines. Hauppauge-based Covaxx, a spinout of United Biomedical Inc., has begun testing its lead vaccine candidate, UB-612, in a Phase 1 human trial in Taiwan. Further trials are planned for Nebraska and Brazil pending regulatory approval.

Pfizer is hustling to scale up production of its vaccine candidate ahead of a possible approval in November, the drugmaker’s U.K. chief said Sunday. Meanwhile, AstraZeneca and the University of Oxford’s shot could snare authorization in the U.K. for high-risk patients by year-end, England’s deputy chief medical officer said. UNICEF is stockpiling single-dose syringes, disposal boxes […]